A Phase II Neo-Adjuvant Study of Cisplatin, Paclitaxel With or Without RAD001 in Patients with Triple-Negative Locally Advanced Breast Cancer

Grant

Date/time Interval

  • May 24, 2012 - January 31, 2015
  • Awarded By

    Total Award Amount

  • 43644.00
  • Direct Costs

  • 34635.00
  • Sponsor Award Id

  • Contributor

  • Carpenter, John   Principal Investigator